UK Prime Minister Keir Starmer says AstraZeneca will invest 300 million pounds, about $405 million, in the country’s life sciences sector. The package is expected to safeguard or create around 1,000 jobs across Macclesfield and Cambridge. Starmer said the move follows a pharmaceutical arrangement involving the United States, signaling fresh confidence in UK biotech growth.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
